Still riding the high of last year’s twice-yearly HIV PrEP approval of lenacapavir as Yeztugo, Gilead Sciences is approaching dealmaking from a “position of strength” as a more mature biopharma, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min "I believe we rarely regret the ...

I didn't like The Legend of Zelda: Tears of the Kingdom much when Nintendo first released it in 2023. It was dull, I incorrectly thought. It was ugly, I accurately concluded. Why bother? This year, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for Americans, reinforcing the company’s long-standing commitment to U.S.-based ...

When animals cry, moths start licking their chops. The less glamorous relatives of butterflies have been known to use their long proboscis to sip the tears of everything from birds to reptiles to even ...

Gilead is hoping to break ground early next year on its Chess Hatch campus as part of its plans to expand its presence in Foster City. The company has been headquartered in Foster City for years, and ...

Hulu has unveiled a first look at “The Testaments,” the upcoming sequel series to “The Handmaid’s Tale.” The series, which is set to premiere in April 2026, is based on “The Handmaid’s Tale” author ...

Hulu revealed that the follow up and next Margaret Atwood adaptation will premiere April 2026, and released a first look at the Gilead daughter of Elisabeth Moss' June, played by Chase Infiniti. By ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development, in the works ...

Gilead Sciences remains a bullish pick, with raised guidance and strong Q3/25 results driving optimism for continued growth. Gilead Sciences' key growth drivers include robust sales from Livdelzi and ...